← Back to patent-cliff list
CAS 1056634-62-8
ethyl 4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzoate
Codes: MOME-005
Application context (from source-drug indications)
MyelofibrosisMomelotinib DihydrochlorideMyeloproliferative neoplasmMomelotinib DihydrochlorideSplenomegalyMomelotinib DihydrochlorideAnaemiaMomelotinib DihydrochlorideVEXAS综合征Momelotinib DihydrochlorideEssential thrombocythaemiaMomelotinib Dihydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Momelotinib Dihydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,4-dichloropyrimidine→(4-(ethoxycarbonyl)phenyl)boronic acid→ethyl 4-(2-chloropyrimidin-4-yl)benzoate→4-morpholinoaniline→ethyl 4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzoate→4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzoic acid→2-aminoacetonitrile hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.